We focus on merging cutting-edge biopharmaceutical developments in our research & development pipeline to accelerate medical advancements and diagnostic technologies for better precision treatments and patient approaches. We provide high quality, accessible biopharmaceuticals as we continue to refine our R&D approach to expand our medical insight into diverse human health conditions and our ability to identify, treat, and prevent disease.
As Seragon expands our portfolio with biopharmaceuticals, we accelerate our discovery process by integrating human genetic and biological research with emerging technologies. We leverage a sophisticated pipeline that optimises every critical process to pursue new therapies and treatments for serious diseases and conditions. From ideation in our labs, to clinical trials, to manufacturing, we commit to a careful, extensive process of safely developing important innovations in science and medicine.
Pharmaceutical business initiatives
We strive to build a scientific-based ecosystem where we continue to keep pace with new possibilities to progress biotechnology and diagnostic research and design patient-focused R&D that generates more meaningful results for patients around the world.
Our long-standing foundation in genomic research and human longevity serves as a critical asset to the development of Seragon’s innovative product line. We continue to research human genetics and disease to design the right approach to refining targeted health assessments to identify and treat diverse human conditions. We aim to grow our accomplishments by improving accuracy in our pipeline, expanding our databases for human genetics and biology, and invest in efficient clinical developments by partnering with competitive industry leaders to operate with better productivity.
Demanding pharmaceutical excellence by leading targeted, patient-focused solutions
Investing in sustainable technologies and production
Seragon’s commitment to long-term impact in our research pipeline design is reinforced by optimised manufacturing facilities, rigorous quality assessment, and sustainable supply chain management to ensure quality in pharmaceutical innovation. New advancements to the way we procure resources and make sure that our products get into our patients require us to be a sustainable pharmaceutical provider. Seragon drives innovative practices to the core of our research and development powerhouse, firmly rooting our approach in making positive contributions to people and to the world.
We believe in channeling the combination of science and technology to supplement the knowledge of Seragon’s researchers and help our patients live healthier, better lives.
Seragon works with suppliers to meet product quality standards, assessing three components to our supply chain to optimise Seragon’s unique approach: our risk assessment and controls; quality management; and ongoing monitoring of our supply chain procurement process.
Risk assessment and control
We identify critical stages along our production process to ensure that we can control and troubleshoot issues in product quality, safety, efficacy, and delivery experience. In order to prioritize our supplier management activities, we work with our suppliers to train and implement risk assessment procedures that safeguard:
- The quality of our pharmaceutical ingredients for drugs and other product components
- Packaging and distribution to consumers.
- Standardized production of high volume or value of Seragon goods and services
We ensure all pharmaceutical products from Seragon meet a standard for production and delivery for consumers. We always work very closely with our suppliers, as well as our third party partners and vendors, to understand how a product is being managed and immediately resolve any issues or risks that arise.
Supply chain procurement process monitoring
We work with our suppliers to source ingredients for Seragon’s products, including materials needed for manufacturing, packaging, and distribution. In order to assess that we are procuring only the highest quality components for our products, we conduct risk assessments and joint activities to:
- measure operational and financial metrics and factors
- find areas to improve efficiency and risk mitigation
Contributing to sustainable pharmaceuticals
At Seragon, we strive to secure a sustainable future for health care opportunities with our biopharmaceutical innovations. When we delve into new research to develop a novel drug or reinvent our current means of targeting human diseases, we keep the people we serve at the forefront of our minds. Our purpose is clear as we grow as a leading provider of patient-focused treatments, continuing a tradition of innovative R&D and sustainability.